P539: PROGNOSTIC RELEVANCE OF MINIMAL RESIDUAL DISEASE IN THERAPY RELATED AND SECONDARY ACUTE MYELOID LEUKEMIA RECEIVING CPX-351 OR FLUDARABINE-BASED INDUCTION.

• F. Guolo,
• P. Minetto,
• C. Riva,
• F. Parodi,
• M. Miglino,
• E. Tedone,
• N. Colombo,
• E. Carminati,
• C. Nurra,
• A. Cagnetta,
• M. Cea,
• R. M. Lemoli

Affiliations

F. Guolo

1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino

P. Minetto

1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino

C. Riva

1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino

F. Parodi

2 University of Genoa

M. Miglino

1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino

E. Tedone

3 Flow Cytometry Unit, Department of Pathological Anatomy

N. Colombo

3 Flow Cytometry Unit, Department of Pathological Anatomy

E. Carminati

4 Molecular Biology Unit, Department of Pathological Anatomy, IRCCS Ospedale Policlinico San Martino, GENOVA, Italy

C. Nurra

4 Molecular Biology Unit, Department of Pathological Anatomy, IRCCS Ospedale Policlinico San Martino, GENOVA, Italy

A. Cagnetta

1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino

M. Cea

1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino

R. M. Lemoli

1 Clinic of Hematology, Department of Internal Medicine (DiMI), IRCCS Ospedale Policlinico San Martino